20th World Congress of Dermatology
?

Searching by Author's name

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

Results of searching?: Paul?C.

IC1243
Prevention of atopic dermatitis flare by pimecrolimus (SDZ ASM 981): a meta-analysis of children and infant studies
P0191
Growth velocity assessments of paediatric patients in long-term vehicle-controlled studies with pimecrolimus (SDZ ASM 981) cream 1%
P0208
Validation of the eczema area and severity index (EASI) for atopic dermatitis in 1,533 patients from the pimecrolimus 1% cream clinical programme
P0214
Pimecrolimus (SDZ ASM 981) cream: a new treatment strategy for the long-term management of atopic dermatitis in infants
P0250
Successful treatment of severe adult atopic dermatitis with low dose methotrexate
P0281
Pimecrolimus (SDZ ASM 981) cream reduces the number of flares and is steroid sparing: a 1-year, double-blind, controlled study in children
P1474
Long-term efficacy of antifungals in toenail onychomycosis: a critical review
P1541
Long-term effectiveness of terbinafine compared to itraconazole in onychomycosis: a 5-year blinded, prospective, follow-up study
P1542
Predicting the success of onychomycosis therapy
P1584
Relationship between terbinafine dose and complete cure rate in tinea capitis
P1585
Terbinafine in tinea capitis: overview of efficacy and safety from randomized double-blind duration-finding trials
P1697
Effect of terbinafine on desipramine pharmacokinetics in extensive CYP2D6 metabolisers
P2016
Long-term safety of cyclosporin (Cy-A) in the treatment of psoriasis: a 5 year cohort study
P2017
Incidence of malignancy during oral cyclosporin (Cy-A) treatment of severe psoriasis


1st TO 5th JULY 2002
PARIS


Back to main menu

Foreword

Oral communications and co-opted speakers abstracts

Poster abstracts

Searching by Author's name

Searching by Article's number

?